Brief: India's Caplin Point Laboratories Dec Qtr Consol Net Profit Rises
Feb 5 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS :
* DEC QUARTER CONSOL NET PROFIT 585.6 MILLION RUPEES
VERSUS
458.3 MILLION RUPEES YEAR AGO
* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 2.28 BILLION
RUPEES
VERSUS 1.59 BILLION RUPEES YEAR AGO
* CAPLIN POINT LABORATORIES LTD - CORONAVIRUS SITUATION AT
CHINA
HAS NO IMPACT ON COMPANY'S OPERATIONS
* CAPLIN POINT LABORATORIES LTD - COMPANY'S MAIN SUPPLIERS
IN
SHIJIAZHUANG HAVE CONTINUED PRODUCTION WITHOUT STOPPAGE
Source text for Eikon: ID:nBSE6xKyN1
Further company coverage: CAPL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees